| Primary |
| Product Used For Unknown Indication |
60.1% |
| Complex Partial Seizures |
13.4% |
| Epilepsy |
9.5% |
| Infantile Spasms |
6.4% |
| Convulsion |
5.3% |
| Grand Mal Convulsion |
1.5% |
| Temporal Lobe Epilepsy |
0.9% |
| Tuberous Sclerosis |
0.6% |
| Partial Seizures |
0.4% |
| Encephalopathy |
0.2% |
| Simple Partial Seizures |
0.2% |
| Status Epilepticus |
0.2% |
| Convulsion Neonatal |
0.2% |
| Drug Abuse |
0.2% |
| Drug Dependence |
0.2% |
| Generalised Non-convulsive Epilepsy |
0.2% |
| Hypersensitivity |
0.2% |
| Inhalation Therapy |
0.2% |
| Wheezing |
0.2% |
| Abnormal Behaviour |
0.1% |
|
| Convulsion |
22.5% |
| Drug Ineffective |
20.1% |
| Drug Dose Omission |
9.0% |
| Visual Field Defect |
8.0% |
| Visual Impairment |
6.6% |
| Malaise |
4.5% |
| Hospitalisation |
4.2% |
| Somnolence |
4.2% |
| Vomiting |
3.1% |
| Abnormal Behaviour |
1.7% |
| Fatigue |
1.7% |
| Incorrect Dose Administered |
1.7% |
| Irritability |
1.7% |
| Pneumonia |
1.7% |
| Status Epilepticus |
1.7% |
| Unevaluable Event |
1.7% |
| Urinary Tract Infection |
1.7% |
| Aggression |
1.4% |
| Death |
1.4% |
| Tremor |
1.4% |
|
| Secondary |
| Product Used For Unknown Indication |
56.3% |
| Epilepsy |
12.8% |
| Complex Partial Seizures |
12.2% |
| Convulsion |
5.2% |
| Infantile Spasms |
4.7% |
| Temporal Lobe Epilepsy |
2.1% |
| Grand Mal Convulsion |
1.4% |
| Inhalation Therapy |
1.1% |
| Tuberous Sclerosis |
0.9% |
| Bronchiectasis |
0.5% |
| Dyspnoea |
0.5% |
| Increased Bronchial Secretion |
0.5% |
| Partial Seizures |
0.4% |
| Hypersensitivity |
0.2% |
| Insomnia |
0.2% |
| Status Epilepticus |
0.2% |
| Urinary Tract Infection |
0.2% |
| Encephalopathy |
0.2% |
| Simple Partial Seizures |
0.2% |
| Constipation |
0.1% |
|
| Convulsion |
25.8% |
| Drug Ineffective |
15.5% |
| Visual Impairment |
7.4% |
| Urinary Tract Infection |
7.1% |
| Drug Dose Omission |
6.7% |
| Somnolence |
4.2% |
| Irritability |
3.9% |
| Visual Field Defect |
3.5% |
| Vomiting |
3.5% |
| Malaise |
2.8% |
| Tremor |
2.8% |
| Incorrect Dose Administered |
2.5% |
| Gastrointestinal Haemorrhage |
2.1% |
| Pneumonia Viral |
2.1% |
| Fatigue |
1.8% |
| Hospitalisation |
1.8% |
| Thinking Abnormal |
1.8% |
| Weight Increased |
1.8% |
| Ataxia |
1.4% |
| Pneumonia |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
71.4% |
| Epilepsy |
14.3% |
| Partial Seizures |
14.3% |
|
| Heart Rate Increased |
50.0% |
| Unevaluable Event |
50.0% |
|
